Celldex Therapeutics | CLDX - Le Chiffre D'Affaires De Vente

Prix De L'Action
33.42
Variation Quotidienne
1.01 3.12%
Mensuellement
7.29%
Annuel
109.66%
Q2 Prévisions
30.13




Ventes Changement Date
AbbVie USD 16.62B 840M 2025-12
Agenus USD 34.2M 3.97M 2025-12
Amgen USD 9.9B 340M 2025-12
Bristol-Myers Squibb USD 12.5B 300M 2025-12
Celldex Therapeutics USD 121K 769K 2025-12
Glaxosmithkline GBP 11.46B 59.16M 2025-12
Nektar Therapeutics USD 21.81M 2.32M 2025-12
Northwest Biotherapeutics USD 200K 245K 2025-09
Pfizer USD 17.58B 880M 2025-12
Rigel Pharmaceuticals USD 55.31M 18.47M 2024-09
Roche Holding CHF 15.65B 274.5M 2025-12